SecBot SecBot
3 ·Filed Jul 9, 2026

VOR

Vor Biopharma Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001193125-26-299666
Form 3, initial insider ownership statement
Actionable Insight • Neutral

This filing confirms David Zaccardelli has become a Section 16 insider (likely a new director or officer); monitor future Form 4 filings for any open-market purchases or sales that could provide signal. No immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$19.14
T+0 close · Jul 9, 2026 · via day close
Latest settled
−2.93%
T+60 · $18.58
Vs SPY
−5.56%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 10 $19.14entry
  2. T+1 · 4mo ago −5.80%α −5.03% · $18.03
  3. T+5 · 4mo ago −9.40%α −8.84% · $17.34
  4. T+20 · 3mo ago +23.67%α +21.24% · $23.67
  5. T+60 · 6w ago −2.93%α −5.56% · $18.58
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

David Zaccardelli filed a Form 3 initial statement of beneficial ownership with Vor Biopharma Inc. on July 9, 2026, reporting a period of July 7, 2026. The filing is an administrative requirement for a new insider, no beneficial ownership details or transaction information were disclosed in the document content. This is a routine filing with no material impact on the company's operations or valuation.

Key Facts

  • Form 3 filed by David Zaccardelli as a new reporting insider of Vor Biopharma Inc.
  • Report period is July 7, 2026; filed on July 9, 2026.
  • No beneficial ownership amounts or share counts were provided in the filing document.
  • The filing includes only a power of attorney authorizing company officers to execute future Section 16 filings.

Financial Impact

No financial impact, initial ownership statement with no disclosed holdings or transactions.

Risk Factors

  • No material risks identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001193125-26-299666
Document: 0001193125-26-299666-index-headers.html0001193125-26-299666
Document: 0001193125-26-299666-index.html0001193125-26-299666
Document: 0001193125-26-299666.txt0001193125-26-299666

Track record

17 reports on VOR

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +70.35% at T+60 after the Jun 8, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $18.97 Now $18.97 −0.00% settles Nov 18
  2. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $19.32 to $19.42 Now $18.97 −1.81% ▲ +0.52% +0.88% vs SPY
  3. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $18.66 to $19.88 Now $18.97 +1.66% ▲ +6.54% +6.23% vs SPY
  4. Oct 30, 202617d ago 424B5 Bearish 4/10 Entry $19.68 to $19.25 Now $18.97 +3.61% ▲ +2.19% +1.71% vs SPY
  5. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $19.68 to $19.25 Now $18.97 −3.61% ▼ −2.19% −1.71% vs SPY
  6. Oct 22, 202625d ago Press Release Bullish 7/10 Entry $18.26 to $18.33 Now $18.97 +3.89% ▲ +0.38% −0.33% vs SPY
  7. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $18.31 to $18.78 Now $18.97 +3.60% ▲ +2.57% +2.81% vs SPY
  8. Sep 29, 20266w ago Press Release Bullish 6/10 Entry $18.33 to $19.08 Now $18.97 +3.49% ▲ +4.09% +4.30% vs SPY
  9. Aug 11, 202613w ago Press Release Neutral 3/10 Entry $23.37 to $22.34 Now $18.97 −18.83% ▼ −4.41% −4.66% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Viewing Entry $19.14 to $18.03 Now $18.97 −0.89% ▼ −5.80% −5.03% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 9, 2026